home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

4th Annual FDA/DIA Statistics Forum

 
  January 26, 2010  
     
 
DIA, North Bethesda, MD 20852-2785
Apr 18 2010 8:00AM - Apr 21 2010 5:00PM


Location:
Marriott Bethesda North Hotel
5701 Marinelli Road
North Bethesda, MD 20852-2785 

Interest Area(s):
Statistics, Clinical Research, Clinical Safety/Pharmacovigilance, Medical Communications, Regulatory Affairs, Research & Development

Overview:
The FDA/DIA Forum provides a venue to discuss important statistical issues associated with the development and review of therapeutic drugs and biologics. The meeting is intended to be an annual, open dialogue to discuss FDA’s issues, initiatives and guidance – emphasizing the statistical and regulatory challenges. 

The conference is an opportunity for statisticians, clinicians and other interested professionals from industry, academia, CROs, and government agencies to learn about and assess current and emerging statistical methodologies and quantitative approaches used to develop evidence of the efficacy and safety of new drug and biologic therapeutic products.

 

Target Audience:

WHO SHOULD ATTEND

·         Statisticians·         Clinicians·         Epidemiologists·         Drug safety professionals·         Regulatory and medical communication scientists

 
 
 
Organized by: Apr 18 2010 8:00AM - Apr 21 2010 5:00PM
Invited Speakers: call contact
 
Deadline for Abstracts: call contact
 
Registration: Contact Information:
Contact Ellen Diegel at the DIA office by telephone +1-215-442-6158, fax +1-215-442-6199 or email Ellen.Diegel@diahome.org.
E-mail: Ellen.Diegel@diahome.org
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.